In Law360, Life Sciences Co-Chair Addresses Life Sciences Dealmaking Climate ahead of JP Morgan Healthcare Conference

In The News
January 10, 2019

Life sciences partner Michael Beauvais (Boston) analyzed the transactions climate in a 2019 JP Morgan Healthcare Conference preview article published Jan. 4 in Law360.

Mr. Beauvais explains that the life sciences industry is starting to shift in market mood, from bullish to cautionary. He predicts an increase in incremental deals, such as bolt-on acquisitions, as well as more carveout divestitures, where companies sell off non-core assets to other strategics as well as private equity.